Abstract
This cohort study examines the association of older age with risk of adverse pathological findings at radical prostatectomy in men with biopsy-confirmed Gleason score 6 prostate cancer.
Highlights
The preferred treatment for men with low-risk prostate cancer, men older than 65 years, is active surveillance.[1]
We investigated whether men older than 65 years had increased odds of adverse pathological findings at radical prostatectomy, defined as TNM category pT3/T4 or R1 or Gleason score 8, 9, or 10, compared with men 65 years and younger
This cohort study found that being older than 65 years was associated with adverse pathological findings at radical prostatectomy
Summary
The preferred treatment for men with low-risk prostate cancer, men older than 65 years, is active surveillance.[1]. To our knowledge, no study has incorporated these factors within predefined age strata to ascertain whether a cohort of patients at high risk can be identified for whom additional evaluation and possible treatment is indicated rather than active surveillance.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
